Log in to save to my catalogue

Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-deriv...

Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-deriv...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_041aa5232fd84ed8be1a33555359e8d7

Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors

About this item

Full title

Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2021-03, Vol.12 (3), p.268-18, Article 268

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Targeting cell division by chemotherapy is a highly effective strategy to treat a wide range of cancers. However, there are limitations of many standard-of-care chemotherapies: undesirable drug toxicity, side-effects, resistance and high cost. New small molecules which kill a wide range of cancer subtypes, with good therapeutic window in vivo, have...

Alternative Titles

Full title

Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_041aa5232fd84ed8be1a33555359e8d7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_041aa5232fd84ed8be1a33555359e8d7

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-020-03269-0

How to access this item